| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
N6,N6-Dimethyl-xylo-adenosine manufacturers
|
| | N6,N6-Dimethyl-xylo-adenosine Basic information |
| Product Name: | N6,N6-Dimethyl-xylo-adenosine | | Synonyms: | N6,N6-Dimethyl-xylo-adenosine;9H-Purin-6-amine, N,N-dimethyl-9-β-D-xylofuranosyl-;(2R,3R,4R,5R)-2-(6-(dimethylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | | CAS: | 669055-52-1 | | MF: | C12H17N5O4 | | MW: | 295.3 | | EINECS: | | | Product Categories: | | | Mol File: | 669055-52-1.mol |  |
| | N6,N6-Dimethyl-xylo-adenosine Chemical Properties |
| Boiling point | 607.3±65.0 °C(Predicted) | | density | 1.71±0.1 g/cm3(Predicted) | | pka | 13.11±0.70(Predicted) |
| | N6,N6-Dimethyl-xylo-adenosine Usage And Synthesis |
| Uses | N6,N6-Dimethyl-xylo-adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
[2] Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500. DOI:10.1016/j.drudis.2021.02.020 |
| | N6,N6-Dimethyl-xylo-adenosine Preparation Products And Raw materials |
|